These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 36252930)

  • 1. Macrophages in Lupus Nephritis: Exploring a potential new therapeutic avenue.
    Kwant LE; Vegting Y; Tsang-A-Sjoe MWP; Kwakernaak AJ; Vogt L; Voskuyl AE; van Vollenhoven RF; de Winther MPJ; Bemelman FJ; Anders HJ; Hilhorst ML
    Autoimmun Rev; 2022 Dec; 21(12):103211. PubMed ID: 36252930
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Extraglomerular immune complex deposition in lupus nephritis.
    Papa V; Brainer J; Henriksen KJ; Cenacchi G; Chang A
    Lupus; 2022 Jan; 31(1):19-27. PubMed ID: 34911399
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinicopathological features and outcomes of SLE patients with renal injury characterised by thrombotic microangiopathy.
    Chen W; Liang S; Zuo K; Yang L; Zeng C; Hu W
    Clin Rheumatol; 2021 Jul; 40(7):2735-2743. PubMed ID: 33543375
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanisms of tissue deposition of immune complexes.
    Mannik M
    J Rheumatol Suppl; 1987 Jun; 14 Suppl 13():35-42. PubMed ID: 2956419
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Revisited Cyclophosphamide in the Treatment of Lupus Nephritis.
    Quan XY; Chen HT; Liang SQ; Yang C; Yao CW; Xu YZ; Liu HF; An N
    Biomed Res Int; 2022; 2022():8345737. PubMed ID: 35707391
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fingerprint and other organised deposits in lupus nephritis.
    Hvala A; Kobenter T; Ferluga D
    Wien Klin Wochenschr; 2000 Aug; 112(15-16):711-5. PubMed ID: 11020962
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pathogenesis and significance of glomerular C4d deposition in lupus nephritis: activation of classical and lectin pathways.
    Kim MK; Maeng YI; Lee SJ; Lee IH; Bae J; Kang YN; Park BT; Park KK
    Int J Clin Exp Pathol; 2013; 6(10):2157-67. PubMed ID: 24133594
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Galectin-3 binding protein links circulating microparticles with electron dense glomerular deposits in lupus nephritis.
    Nielsen CT; Østergaard O; Rekvig OP; Sturfelt G; Jacobsen S; Heegaard NH
    Lupus; 2015 Oct; 24(11):1150-60. PubMed ID: 25837289
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mesangial cell: A hub in lupus nephritis.
    Liu M; Zhang L; Wang Y; Hu W; Wang C; Wen Z
    Front Immunol; 2022; 13():1063497. PubMed ID: 36591251
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Decipher the Immunopathological Mechanisms and Set Up Potential Therapeutic Strategies for Patients with Lupus Nephritis.
    Tsai CY; Li KJ; Shen CY; Lu CH; Lee HT; Wu TH; Ng YY; Tsao YP; Hsieh SC; Yu CL
    Int J Mol Sci; 2023 Jun; 24(12):. PubMed ID: 37373215
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma C4d Correlates With C4d Deposition in Kidneys and With Treatment Response in Lupus Nephritis Patients.
    Martin M; Trattner R; Nilsson SC; Björk A; Zickert A; Blom AM; Gunnarsson I
    Front Immunol; 2020; 11():582737. PubMed ID: 33133102
    [TBL] [Abstract][Full Text] [Related]  

  • 12. "Kill" the messenger: Targeting of cell-derived microparticles in lupus nephritis.
    Nielsen CT; Rasmussen NS; Heegaard NH; Jacobsen S
    Autoimmun Rev; 2016 Jul; 15(7):719-25. PubMed ID: 26970484
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Study of lupus nephritis: its classification and the significance of subendothelial deposits.
    Tateno S; Kobayashi Y; Shigematsu H; Hiki Y
    Q J Med; 1983; 52(207):311-31. PubMed ID: 6359226
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patterns of renal injury in systemic lupus erythematosus: light and immunofluorescence microscopic observations.
    Grishman E; Gerber MA; Churg J
    Am J Kidney Dis; 1982 Jul; 2(1 Suppl 1):135-41. PubMed ID: 6213149
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lupus Podocytopathy: An Overview.
    Oliva-Damaso N; Payan J; Oliva-Damaso E; Pereda T; Bomback AS
    Adv Chronic Kidney Dis; 2019 Sep; 26(5):369-375. PubMed ID: 31733721
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibodies targeting circulating protective molecules in lupus nephritis: Interest as serological biomarkers.
    Dumestre-Pérard C; Clavarino G; Colliard S; Cesbron JY; Thielens NM
    Autoimmun Rev; 2018 Sep; 17(9):890-899. PubMed ID: 30009962
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characteristics and renal survival of patients with lupus nephritis with glomerular immunoglobulin G
    Jiang X; Lan L; Zhou Q; Wang H; Wang H; Chen J; Han F
    Lupus Sci Med; 2022 Jun; 9(1):. PubMed ID: 35710146
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Class IV-S versus class IV-G lupus nephritis: clinical and morphologic differences suggesting different pathogenesis.
    Hill GS; Delahousse M; Nochy D; Bariéty J
    Kidney Int; 2005 Nov; 68(5):2288-97. PubMed ID: 16221231
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nucleosomes contribute to increase mesangial cell chemokine expression during the development of lupus nephritis.
    Kanapathippillai P; Hedberg A; Fenton CG; Fenton KA
    Cytokine; 2013 May; 62(2):244-52. PubMed ID: 23561928
    [TBL] [Abstract][Full Text] [Related]  

  • 20. C-reactive protein, immunoglobulin G and complement co-localize in renal immune deposits of proliferative lupus nephritis.
    Sjöwall C; Olin AI; Skogh T; Wetterö J; Mörgelin M; Nived O; Sturfelt G; Bengtsson AA
    Autoimmunity; 2013 May; 46(3):205-14. PubMed ID: 23331132
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.